Back to dashboard
CommercialCoverageMedium impact

Policy Criteria Change-Material Amendment

Arkansas Blue Cross Blue Shield·AR · Cardiology, Hematology, OB-GYN +2 more·Medical Policy
Effective date
Sep 15, 2026
We identified it
Jun 19, 2026
Days to comply
87 days

Summary

Effective September 15, 2026, Arkansas Blue Cross will no longer cover venous and arterial thrombosis risk testing for women age 50 or less who smoke and have a history of myocardial infarction (MI). This specific indication has been removed from the coverage criteria based on updated ACMG guidelines.

Action Required

Before Sep 15, 2026
Before September 15, 2026: Billing team must update system to flag claims for venous and arterial thrombosis risk testing (protein C, protein S, antithrombin III deficiency testing) for women age 50 or less who smoke with MI history as non-covered for Arkansas Blue Cross members. Providers should be notified to order alternative testing or seek different diagnostic approaches for this patient population. Claims for this specific indication will be denied after the effective date.